Clinical Trials Sponsored by Igenica Biotherapeutics, Inc.
Total 192 results
-
Igenica Biotherapeutics, Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Stealth BioTherapeutics Inc.Not yet recruiting
-
Sonoma Biotherapeutics, Inc.RecruitingHidradenitis SuppurativaUnited States
-
D2M Biotherapeutics Inc.RecruitingAdvanced Solid TumorUnited States
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States
-
Worg Biotherapeutics Inc.RecruitingGraves DiseaseUnited States
-
Perceive Biotherapeutics, Inc.RecruitingAge-Related Macular DegenerationAustralia, Israel
-
Bolt Biotherapeutics, Inc.RecruitingClear Cell Renal Cell Carcinoma | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung CancerUnited States
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, Netherlands, Sweden
-
Artiva Biotherapeutics, Inc.Not yet recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Capsida Biotherapeutics, Inc.Not yet recruitingSTXBP1 Encephalopathy With Epilepsy
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Stage IV Non-small Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
Claris Biotherapeutics, Inc.RecruitingNeurotrophic KeratitisUnited States, Canada
-
Iovance Biotherapeutics, Inc.RecruitingCervical CarcinomaUnited States, Spain, United Kingdom, Germany, France, Italy, Netherlands, Switzerland
-
CardioVascular BioTherapeutics, Inc.Not yet recruitingMyocardial Ischemia | Coronary Disease | Coronary Heart Disease | Coronary Arteriosclerosis
-
Stealth BioTherapeutics Inc.Active, not recruitingMitochondrial Diseases | Mitochondrial Myopathies | Mitochondrial Complex I Deficiency | Mitochondrial Pathology | Mitochondrial DNA Depletion | Mitochondrial DNA Mutation | Mitochondrial DNA Deletion | Mitochondrial Metabolism DefectSpain, United States, Italy, Netherlands, Australia, Germany, Hungary, New Zealand, Norway, United Kingdom
-
Arcutis Biotherapeutics, Inc.CompletedAtopic Dermatitis EczemaUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedAtopic Dermatitis EczemaUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedScalp PsoriasisUnited States, Canada
-
Stealth BioTherapeutics Inc.AvailableMitochondrial Diseases | Barth Syndrome
-
Sensei Biotherapeutics, Inc.TerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Steminent Biotherapeutics Inc.Completed
-
Arcutis Biotherapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Stealth BioTherapeutics Inc.TerminatedPrimary Mitochondrial MyopathyUnited States, Germany, Canada, Italy, United Kingdom, Denmark, Hungary
-
Stealth BioTherapeutics Inc.TerminatedPrimary Mitochondrial DiseaseUnited States
-
Sensei Biotherapeutics, Inc.WithdrawnMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia (CMML)
-
Stealth BioTherapeutics Inc.TerminatedRenal Artery Obstruction | Ischemia Reperfusion Injury | Hypertension, RenovascularUnited States
-
Stealth BioTherapeutics Inc.CompletedHeart FailureNetherlands, Italy, United Kingdom
-
Stealth BioTherapeutics Inc.CompletedMitochondrial MyopathyUnited States
-
Prometic Biotherapeutics, Inc.CompletedHypoplasminogenemia | Type I Plasminogen DeficiencyUnited States
-
Stealth BioTherapeutics Inc.CompletedAge-related Macular Degeneration | Diabetic Macular EdemaUnited States
-
Stealth BioTherapeutics Inc.Withdrawn
-
Garnet BioTherapeutics, Inc.CompletedScar FormationUnited States
-
Nitric BioTherapeutics, IncTerminated
-
Stealth BioTherapeutics Inc.CompletedHealthy VolunteersUnited States
-
Salubris Biotherapeutics IncRecruitingHeart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection FractionUnited States
-
REMD Biotherapeutics, Inc.RecruitingType 1 Diabetes MellitusUnited States
-
Sonoma Biotherapeutics, Inc.RecruitingRheumatoid ArthritisUnited States
-
1ST Biotherapeutics, Inc.Not yet recruitingAmyotrophic Lateral Sclerosis (ALS) | Parkinson Disease Psychosis
-
Conjupro Biotherapeutics, Inc.RecruitingCancer | Cancer, LungUnited States, Canada
-
Bridge Biotherapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Korea, Republic of, Australia, Israel, Poland
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
Iovance Biotherapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Perceive Biotherapeutics, Inc.Active, not recruitingAge-related Macular Degeneration | Geographic AtrophyUnited States
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedChronic Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Sonoma Biotherapeutics, Inc.Active, not recruiting
-
Arcutis Biotherapeutics, Inc.CompletedMaximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)Psoriasis | Plaque PsoriasisUnited States, Canada, Dominican Republic
-
Bridge Biotherapeutics, Inc.TerminatedNSCLCKorea, Republic of